Hospitalized Community-acquired Pneumonia Due to Streptococcus Pneumoniae: Has Resistance to Antibiotics Decreased?
From: Institut Clínic de Pneumologia i Cirurgia Toràcica, Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Chest
- Publish Date: Sep 2006
- ISSN: 0012-3692
- Volume: 130
- Issue: 3
- Pages: 800-6
- Medium: Print
- Language: English
- Citation (JAMA): Vallès Xavier, Marcos Angeles, Pinart Mariona, et al. Hospitalized Community-acquired Pneumonia Due to Streptococcus Pneumoniae: Has Resistance to Antibiotics Decreased?. Chest Sep 2006;130:800-6
Abstract
STUDY OBJECTIVES: To determine the incidence and trends of pneumococcal community-acquired pneumonia (CAP) resistant to antibiotics, to describe clinical and microbiological features of pneumococcal CAP, and to ascertain prognostic risk factors in a third-level hospital. Design and setting: We performed a prospective study of all well-defined pneumococcal CAP hospitalizations in the Hospital Clínic de Barcelona (Spain) over 2 years of follow-up, and results were compared with a previous study. MEASUREMENTS AND RESULTS: One hundred twenty-five patients were included (mean age, 59.6 years; 71.2% male and 28.8% female). Mortality was 7% (n = 9). Twenty-four percent were HIV-1 seropositive (n = 30), and 53% had at least one comorbidity (n = 65). Nonsusceptibility to penicillin, ceftriaxone, and erythromycin accounted for 34%, 9%, and 33%, respectively. A decrease in penicillin (p = 0.01) and cephalosporin (p < 0.001) resistance was observed on comparison with a previous study, while macrolide resistance remained unchanged. Serotype 1 infection was overrepresented (8%, n = 10). A bad outcome was related to female gender (relative risk [RR], 9.1; confidence interval [CI], 1.3 to 61.3), pleural effusion (RR, 13.35; CI, 1.9 to 93.1), and prior oral corticoid intake (RR, 10.59; CI, 1.2 to 91.2), whereas drug-resistant strains were not. CONCLUSIONS: We found a decrease in drug resistance compared with a previous report and a relatively high incidence of serotype 1 pneumococcal CAP. We also observed a high prevalence of HIV-1 infection among individuals with pneumococcal pneumonia. We confirm the lack of association of drug resistance with mortality and length of hospitalization. Mortality was associated with female gender, pleural effusion, and previous oral corticoid treatment. These results should be better ascertained in further studies.
Mesh Headings (Keywords): Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Cohort Studies, Community-Acquired Infections, Disease Susceptibility, Drug Resistance, Bacterial, Female, Hospital Mortality, Hospitalization, Humans, Incidence, Macrolides, Male, Middle Aged, Pneumonia, Pneumococcal, Prognosis, Prospective Studies, Risk Factors, Spain, Streptococcus pneumoniae, Survival Analysis, beta-Lactams
Check for Full Text / PubMed Unique Identifier (PMID): 16963678
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.